CR9008A - Nuevo procedimiento y compuestos intermedios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenilmetilsulfonamida - Google Patents
Nuevo procedimiento y compuestos intermedios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenilmetilsulfonamidaInfo
- Publication number
- CR9008A CR9008A CR9008A CR9008A CR9008A CR 9008 A CR9008 A CR 9008A CR 9008 A CR9008 A CR 9008A CR 9008 A CR9008 A CR 9008A CR 9008 A CR9008 A CR 9008A
- Authority
- CR
- Costa Rica
- Prior art keywords
- azetidin
- phenylmetilsulfonamide
- benzhidril
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Nuevo procedimiento de sintesis de N-(1-bis-(clorofenil) meti)azetidin-3-il)-N(3,5-difluorofenil)-metilsulfonamida
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410845A FR2876689B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9008A true CR9008A (es) | 2007-10-01 |
Family
ID=34953744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9008A CR9008A (es) | 2004-10-14 | 2007-03-21 | Nuevo procedimiento y compuestos intermedios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenilmetilsulfonamida |
Country Status (32)
Country | Link |
---|---|
US (3) | US7429668B2 (es) |
EP (1) | EP1802571B1 (es) |
JP (1) | JP4971986B2 (es) |
KR (1) | KR20070063540A (es) |
CN (1) | CN101039903A (es) |
AR (1) | AR051389A1 (es) |
AT (1) | ATE534624T1 (es) |
AU (1) | AU2005293453A1 (es) |
BR (1) | BRPI0516526A (es) |
CA (1) | CA2581781A1 (es) |
CR (1) | CR9008A (es) |
CY (1) | CY1112390T1 (es) |
DK (1) | DK1802571T3 (es) |
EA (2) | EA012523B1 (es) |
ES (1) | ES2378181T3 (es) |
FR (1) | FR2876689B1 (es) |
HR (1) | HRP20120168T1 (es) |
IL (1) | IL182277A0 (es) |
MA (1) | MA29005B1 (es) |
ME (1) | ME01297B (es) |
MX (1) | MX2007004483A (es) |
NO (1) | NO20072431L (es) |
PL (1) | PL1802571T3 (es) |
PT (1) | PT1802571E (es) |
RS (1) | RS52132B (es) |
SG (2) | SG144920A1 (es) |
SI (1) | SI1802571T1 (es) |
TN (1) | TNSN07115A1 (es) |
TW (1) | TW200626542A (es) |
UY (1) | UY29165A1 (es) |
WO (1) | WO2006040464A1 (es) |
ZA (1) | ZA200703011B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925050B1 (fr) * | 2007-12-14 | 2010-01-08 | Sanofi Aventis | Nouveau procede de preparation de derives d'azetidine |
JP5599878B2 (ja) * | 2009-06-29 | 2014-10-01 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | 1−アミノ−1,3,3,5,5−ペンタメチルシクロヘキサンを調製する方法 |
SI2448910T1 (sl) * | 2009-06-29 | 2013-07-31 | Merz Pharma Gmbh & Co. Kgaa | Postopek za pripravo nerameksana |
CN107089918B (zh) * | 2017-04-08 | 2020-06-16 | 迪嘉药业集团有限公司 | 一种盐酸二苯甲胺的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9714129D0 (en) * | 1997-07-04 | 1997-09-10 | Pfizer Ltd | Azetidines |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
-
2004
- 2004-10-14 FR FR0410845A patent/FR2876689B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 JP JP2007536213A patent/JP4971986B2/ja not_active Expired - Fee Related
- 2005-10-10 SI SI200531476T patent/SI1802571T1/sl unknown
- 2005-10-10 ME MEP-2012-19A patent/ME01297B/me unknown
- 2005-10-10 RS RS20120060A patent/RS52132B/en unknown
- 2005-10-10 AU AU2005293453A patent/AU2005293453A1/en not_active Withdrawn
- 2005-10-10 SG SG200805167-4A patent/SG144920A1/en unknown
- 2005-10-10 WO PCT/FR2005/002489 patent/WO2006040464A1/fr active Application Filing
- 2005-10-10 BR BRPI0516526-1A patent/BRPI0516526A/pt not_active IP Right Cessation
- 2005-10-10 KR KR1020077008412A patent/KR20070063540A/ko not_active Application Discontinuation
- 2005-10-10 EA EA200700842A patent/EA012523B1/ru not_active IP Right Cessation
- 2005-10-10 AT AT05809316T patent/ATE534624T1/de active
- 2005-10-10 MX MX2007004483A patent/MX2007004483A/es active IP Right Grant
- 2005-10-10 ZA ZA200703011A patent/ZA200703011B/xx unknown
- 2005-10-10 DK DK05809316.2T patent/DK1802571T3/da active
- 2005-10-10 EP EP05809316A patent/EP1802571B1/fr active Active
- 2005-10-10 CA CA002581781A patent/CA2581781A1/fr not_active Abandoned
- 2005-10-10 PL PL05809316T patent/PL1802571T3/pl unknown
- 2005-10-10 SG SG200805168-2A patent/SG144921A1/en unknown
- 2005-10-10 CN CNA2005800350930A patent/CN101039903A/zh active Pending
- 2005-10-10 ES ES05809316T patent/ES2378181T3/es active Active
- 2005-10-10 PT PT05809316T patent/PT1802571E/pt unknown
- 2005-10-10 EA EA200801990A patent/EA200801990A1/ru unknown
- 2005-10-13 TW TW094135609A patent/TW200626542A/zh unknown
- 2005-10-13 AR ARP050104295A patent/AR051389A1/es unknown
- 2005-10-14 UY UY29165A patent/UY29165A1/es unknown
-
2007
- 2007-03-21 CR CR9008A patent/CR9008A/es not_active Application Discontinuation
- 2007-03-28 IL IL182277A patent/IL182277A0/en unknown
- 2007-03-28 US US11/692,462 patent/US7429668B2/en active Active
- 2007-03-28 TN TNP2007000115A patent/TNSN07115A1/fr unknown
- 2007-05-04 MA MA29868A patent/MA29005B1/fr unknown
- 2007-05-11 NO NO20072431A patent/NO20072431L/no not_active Application Discontinuation
-
2008
- 2008-08-20 US US12/194,644 patent/US7652154B2/en active Active
-
2009
- 2009-12-11 US US12/635,965 patent/US8071788B2/en active Active
-
2012
- 2012-02-20 HR HR20120168T patent/HRP20120168T1/hr unknown
- 2012-02-23 CY CY20121100184T patent/CY1112390T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
ATE459603T1 (de) | Pyridinaminosulfonylsubstituierte benzamide als inhibitoren von cytochrom p450 3a4 (cyp3a4) | |
MY136800A (en) | Inhibitors of the interaction between mdm2 and p53 | |
TNSN07196A1 (en) | Potentiators of glutamate receptors | |
TW200801003A (en) | Novel compounds | |
TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
EP1765335A4 (en) | PYRAZOLAMIDE DERIVATIVES, COMPOSITIONS AND METHODS OF APPLYING THESE COMPOUNDS | |
TW200716529A (en) | New compounds II | |
TW200624426A (en) | BACE inhibitors | |
TW200638930A (en) | Acetylene derivatives | |
TW200738649A (en) | Calcilytic compounds | |
TW200740781A (en) | Novel compounds | |
UA96277C2 (en) | Benzimidazole derivatives | |
WO2006023883A3 (en) | T type calcium channel inhibitors | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
IL200469A0 (en) | Benzimidazole derivatives | |
TW200730512A (en) | Novel compounds | |
SE0303541D0 (sv) | New compounds | |
MX2007003398A (es) | Sulfonamidas y sus usos. | |
NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
CR9008A (es) | Nuevo procedimiento y compuestos intermedios de preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n-fenilmetilsulfonamida | |
TW200720262A (en) | Novel compounds ii | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
MXPA05010651A (es) | Compuestos de pirazol. | |
SE0402284D0 (sv) | New heterocyclic amides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |